This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1980 Jan;9(1):91-4.

doi: 10.1111/j.1365-2125.1980.tb04802.x.

Saliva: plasma concentration relationships for sulphapyridine following sulphasalazine administration to normal volunteers and patients with inflammatory bowel disease

J M Day, J B Houston

PMID: 6101957
PMCID: PMC1429913
DOI: 10.1111/j.1365-2125.1980.tb04802.x

Saliva: plasma concentration relationships for sulphapyridine following sulphasalazine administration to normal volunteers and patients with inflammatory bowel disease

J M Day et al. Br J Clin Pharmacol. 1980 Jan.

. 1980 Jan;9(1):91-4.

doi: 10.1111/j.1365-2125.1980.tb04802.x.

Authors

J M Day, J B Houston

PMID: 6101957
PMCID: PMC1429913
DOI: 10.1111/j.1365-2125.1980.tb04802.x

No abstract available

PubMed Disclaimer

Similar articles

Comparative pharmacokinetics of sulphasalazine and sulphapyridine after rectal and oral administration to patients with ulcerative colitis.
Allgayer H, Kruis W, Eisenburg J, Paumgartner G. Allgayer H, et al. Eur J Clin Pharmacol. 1984;26(2):275-7. doi: 10.1007/BF00630300. Eur J Clin Pharmacol. 1984. PMID: 6144549
Acetylation polymorphism of sulfapyridine in patients with ulcerative colitis and Crohn's disease.
Das KM, Eastwood MA. Das KM, et al. Clin Pharmacol Ther. 1975 Nov;18(5 Pt 1):514-20. doi: 10.1002/cpt1975185part1514. Clin Pharmacol Ther. 1975. PMID: 241531
Salivary excretion and pharmacokinetics of sulfapyridine after sulfasalazine.
Bates TR, Blumenthal HP, Pieniaszek HJ Jr. Bates TR, et al. Clin Pharmacol Ther. 1977 Dec;22(6):917-27. doi: 10.1002/cpt1977226917. Clin Pharmacol Ther. 1977. PMID: 21768
Clinical pharmacokinetics of sulphasalazine, its metabolites and other prodrugs of 5-aminosalicylic acid.
Klotz U. Klotz U. Clin Pharmacokinet. 1985 Jul-Aug;10(4):285-302. doi: 10.2165/00003088-198510040-00001. Clin Pharmacokinet. 1985. PMID: 2864155 Review.
Clinical pharmacokinetics of sulphasalazine.
Das KM, Dubin R. Das KM, et al. Clin Pharmacokinet. 1976 Nov-Dec;1(6):406-25. doi: 10.2165/00003088-197601060-00002. Clin Pharmacokinet. 1976. PMID: 15752 Review.

See all similar articles

Cited by

Acetylator phenotype and serum levels of sulfapyridine in patients with inflammatory bowel disease.
Sharp ME, Wallace SM, Hindmarsh KW, Brown MA. Sharp ME, et al. Eur J Clin Pharmacol. 1981;21(3):243-50. doi: 10.1007/BF00627927. Eur J Clin Pharmacol. 1981. PMID: 6119205 No abstract available.
Azo reduction of sulphasalazine in healthy volunteers.
Houston JB, Day J, Walker J. Houston JB, et al. Br J Clin Pharmacol. 1982 Sep;14(3):395-8. doi: 10.1111/j.1365-2125.1982.tb01997.x. Br J Clin Pharmacol. 1982. PMID: 6127096 Free PMC article.

References

1. Clin Pharmacol Ther. 1977 Dec;22(6):917-27 - PubMed
1. J Chromatogr. 1979 Feb 21;162(2):237-43 - PubMed
1. Acta Pharm Suec. 1973 Mar;10(1):87-92 - PubMed
1. Lancet. 1978 Feb 4;1(8058):277 - PubMed
1. Lancet. 1977 Oct 29;2(8044):892-5 - PubMed

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information